Shares of SunOpta, Inc. (NASDAQ:STKL - Get Free Report) TSE: SOY shot up 13.3% during trading on Thursday after the company announced better than expected quarterly earnings. The company traded as high as $6.30 and last traded at $5.88. 474,858 shares traded hands during mid-day trading, a decline of 45% from the average session volume of 871,071 shares. The stock had previously closed at $5.19.
The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. SunOpta had a positive return on equity of 12.82% and a negative net margin of 0.66%. The company had revenue of $191.49 million during the quarter, compared to the consensus estimate of $185.36 million.
Insider Buying and Selling at SunOpta
In related news, CEO Brian W. Kocher purchased 10,000 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were acquired at an average cost of $5.72 per share, with a total value of $57,200.00. Following the completion of the purchase, the chief executive officer owned 10,000 shares of the company's stock, valued at $57,200. The trade was a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.90% of the company's stock.
Institutional Investors Weigh In On SunOpta
A number of institutional investors have recently modified their holdings of the company. Quarry LP purchased a new stake in shares of SunOpta in the 4th quarter worth about $36,000. Bank of Montreal Can acquired a new position in SunOpta in the 2nd quarter valued at about $68,000. EP Wealth Advisors LLC lifted its stake in SunOpta by 11.9% in the first quarter. EP Wealth Advisors LLC now owns 16,477 shares of the company's stock valued at $80,000 after buying an additional 1,747 shares during the last quarter. State of Wyoming acquired a new stake in SunOpta in the first quarter valued at $81,000. Finally, Bayesian Capital Management LP raised its holdings in shares of SunOpta by 15.2% in the 4th quarter. Bayesian Capital Management LP now owns 11,536 shares of the company's stock worth $89,000 after purchasing an additional 1,523 shares during the period. 85.39% of the stock is owned by institutional investors.
SunOpta Stock Up 0.1%
The stock has a fifty day moving average price of $6.04 and a two-hundred day moving average price of $5.81. The firm has a market capitalization of $736.39 million, a P/E ratio of -104.42 and a beta of 1.32. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.39 and a current ratio of 0.96.
SunOpta Company Profile
(
Get Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Recommended Stories
Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.